Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Inventory (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Change in Inventory data on record, last reported at -$2.3 million in Q2 2025.

  • For Q2 2025, Change in Inventory fell 845.63% year-over-year to -$2.3 million; the TTM value through May 2025 reached -$7.7 million, down 791.88%, while the annual FY2025 figure was -$7.7 million, 791.88% down from the prior year.
  • Change in Inventory reached -$2.3 million in Q2 2025 per LFCR's latest filing, up from -$4.6 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $12.2 million in Q4 2022 and bottomed at -$9.7 million in Q2 2022.
  • Average Change in Inventory over 5 years is $383444.4, with a median of -$140000.0 recorded in 2023.
  • The widest YoY moves for Change in Inventory: up 958.33% in 2024, down 895.08% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $10.3 million in 2021, then grew by 17.92% to $12.2 million in 2022, then crashed by 102.01% to -$244000.0 in 2023, then plummeted by 895.08% to -$2.4 million in 2024, then grew by 5.11% to -$2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$2.3 million in Q2 2025, -$4.6 million in Q1 2025, and -$2.4 million in Q4 2024.